Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Felix
Relationship:   Director, 10% Owner
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   927,207    

Indirect Shares

   141,861,898      
Direct Value   $82,119,756    

Indirect Value

   $12,961,771,173      
Total Shares   142,789,105      
Total Value   $13,043,890,929      


Incyte Corp $32,589,847 Seagen Inc $49,182,531 Synageva BioPharma Corp $0 Genomic Health Inc $18,271 Biocryst Pharmaceuticals Inc $312,474 Neurogene $16,634 Incyte Corp $32,589,847 Seagen Inc $49,182,531 Synageva BioPharma Corp $0 Genomic Health Inc $18,271 Biocryst Pharmaceuticals Inc $312,474 Neurogene $16,634
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    36   
    6    

     Stock price went up :
    15   
    6    
     Stock price went down :
    21   
    0    
   
     Gain/Loss Ratio :
   0.0   
   6.0   
     Percentage Gain/Loss :
   -24.3%
 18.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Incyte Corp INCY Director, 10% Owner 2023-09-29 559,963 2023-09-29 33,480,292    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2003-10-06 0 2012-02-01 116,454    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2018-02-01 215,015 2018-02-01 44,355,335    Premium*  
            Synageva BioPharma Corp GEVA Director, 10% Owner 2015-06-22 100,503 2015-06-22 9,328,233    Premium*  
            Viropharma Inc VPHM 10% Owner 2005-01-31 0 2011-12-14 303,264    Premium*  
            Aceragen, Inc ACGN Director 0 2017-07-03 145,453    Premium*  
            Tapestry Pharmaceuticals Inc TPPHQ 10% Owner 0 2008-10-15 0    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2012-10-01 288 2012-10-01 11,377,485    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 0 2009-02-06 1,629    Premium*  
            Biocryst Pharmaceuticals Inc BCRX 10% Owner 2016-08-16 46,918 2016-08-16 9,418,390    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2011-06-30 5,266,568    Premium*  
            Adolor Corp ADLR 10% Owner 2010-04-26 0 2011-12-19 0    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2010-07-28 140,525    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 0 2011-08-22 1,809    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 57,704    Premium*  
            XOMA Corporation XOMA Director, 10% Owner 2012-10-29 0 2012-10-29 480,639    Premium*  
            Neurogene NGNE 10% Owner 2015-08-07 4,520 0    Premium*  
            Invitae Corp NVTA 10% Owner 0 2015-08-27 6,554,967    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 0 2015-12-24 4,865,647    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2022-01-21 0 2022-06-06 15,967,504    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
SGEN Seagen Inc Director   –       •       •   2005-03-23 4/A B $4.96 $26,156 I/I 5,274 11,155 2.25 -
SGEN Seagen Inc Director   –       •       •   2006-08-03 4/A B $4.00 $24,140 I/I 6,040 1,406,781 2.17 -
SGEN Seagen Inc Director   –       •       •   2006-08-03 4/A B $4.00 $74,079 I/I 18,535 3,753,076 2.25 -
SGEN Seagen Inc Director   –       •       •   2006-08-03 4/A B $4.00 $1,699 I/I 425 86,061 2.17 -
SGEN Seagen Inc Director   –       •       •   2006-08-04 4/A B $4.05 $23,481 I/I 5,798 1,412,579 2.17 -
SGEN Seagen Inc Director   –       •       •   2006-08-04 4/A B $4.05 $72,058 I/I 17,793 3,770,869 2.25 -
SGEN Seagen Inc Director   –       •       •   2006-08-04 4/A B $4.05 $1,656 I/I 409 86,470 2.17 -
SGEN Seagen Inc Director   –       •       •   2006-08-07 4/A B $4.03 $37,719 I/I 9,350 1,421,929 2.25 -
SGEN Seagen Inc Director   –       •       •   2006-08-07 4/A B $4.03 $115,746 I/I 28,692 3,799,561 2.25 -
SGEN Seagen Inc Director   –       •       •   2006-08-07 4/A B $4.03 $2,654 I/I 658 87,128 2.17 -
SGEN Seagen Inc Director   –       •       •   2006-08-08 4/A B $4.05 $688 I/I 170 87,298 2.17 -
SGEN Seagen Inc Director   –       •       •   2006-08-08 4/A B $4.05 $30,010 I/I 7,414 3,806,975 2.25 -
SGEN Seagen Inc Director   –       •       •   2006-08-08 4/A B $4.05 $9,779 I/I 2,416 1,424,345 2.17 -
SGEN Seagen Inc Director   –       •       •   2006-08-09 4/A B $4.05 $18,152 I/I 4,482 91,780 2.17 -
SGEN Seagen Inc Director   –       •       •   2006-08-09 4/A B $4.05 $791,152 I/I 195,347 4,002,322 2.25 -
SGEN Seagen Inc Director   –       •       •   2006-08-09 4/A B $4.05 $257,810 I/I 63,657 1,488,002 2.25 -
SGEN Seagen Inc Director   –       •       •   2007-02-14 4/A S $8.76 $171,354 I/I (19,561) 75,598 0 -
GHDX Genomic Health Inc Director   –       •       •   2007-05-21 4/A A $15.50 $27,947 I/I 1,803 190,341 0 -
GHDX Genomic Health Inc Director   –       •       •   2007-05-21 4/A B $15.50 $348,611 I/I 22,491 60,958 2.25 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2008-07-28 4/A S $14.87 $2,707 I/I (182) 13,473 0 -
ACGN Aceragen, Inc 10% Owner   –       –       •   2008-07-29 4/A S $14.93 $9,048 I/I (606) 12,867 0 -
INCY Incyte Corp Director   –       •       •   2008-12-19 4/A B $3.60 $1,429 I/I 397 284,422 2.17 -
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2008-12-19 4/A B $11.14 $44,449 I/I 3,990 99,636 1.5 -
INCY Incyte Corp Director   –       •       •   2008-12-22 4/A B $3.25 $39 I/I 12 3,475,852 2.17 -
INCY Incyte Corp Director   –       •       •   2008-12-22 4/A B $3.25 $10 I/I 3 179,345 2.17 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us